The iplexmed electronic RDT is based on graphene field-effect transistors that show an extremely high sensitivity as compared to other existing sensing technologies.
Graphene is a bidimensional material that behaves as a zero-gap semiconductor, and can be used to form ambipolar transistors with a high charge carrier mobility. Behind the technicalities, the consequence is graphene is able to provide record levels of sensitivity and can detect extremely low levels of infectious agents
Most kinds of Rapid Diagnosis Tests (RDT) available today are based on proteins. Think of pregnancy tests. While these tests have served us well for the preivous decades, they have limitations: limited temperature stability, limited shelf life. They also have hard time discriminating closely related species of pathogens. It means one can obtain the level of detection only obtain in laboratory-grade detection using amplification techniques (PCR), while being portable.
Our sensors are based on DNA, the code of life. This makes them able to detect much more accurately infectious agents, and discriminate them very closely, and provide the best diagnosis possible.
Our high-technology portable sensor platform is able to embed several probes to detect simultaneously several agents, and discriminate them, providing wide panels of biomarkers for clinician to analyze.